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Aim
The prospect that immune activation or inflammation
may be directly related to the increased incidence in
HIV infected donors of manifestations that are reminis-
cent of the human aging process (i.e. cardiovascular dis-
ease, malignancies, osteoporosis, cognitive impairment,
depression and frailty) is raising increasing concerns. On
the immunological side, in addition to promoting viral
replication as well as CD4
+ Tc e l la p o p t o s i s ,H I Va s s o -
ciated immune activation may also lead to an acceler-
ated decline of immune competence resembling the
phenomenon of immunosenescence. Our aim is to
explore further the potential relationship between
immune activation, HIV disease progression and
immunosenescence.
Materials and methods
We performed a comparative analysis of immunologic
markers in different groups of HIV infected donors and
healthy controls. The initial investigation of blood lym-
phocyte populations led us rapidly to turn our attention
onto the lymphocyte primary immune resources, i.e. the
CD34
+ hematopoietic progenitor cells (studied directly
from the blood of patients).
Results
Human aging and HIV-1 infection exhibit a number of
parallels with regards to immunological attributes, that
are evocative of premature immunosenescence in HIV-1
infected patients and reflect a reduced production of
lymphocytes. Analyses of CD34
+ hematopoietic progeni-
tor cell number, phenotype and clonogenic potential
underline a manifest impairment of primary immune
resources with age or HIV-1 infection. Systemic immune
activation emerges as a major correlate of altered lym-
phopoiesis, which can be partially reversed with pro-
longed antiretroviral therapy. Poor CD4
+ T cell count
recovery despite successful virological response on anti-
retroviral treatment is associated with persistent damage
to the lymphopoietic system.
Discussion
Our findings provide new insights into the
consequences of persistent immune activation in HIV-1
infection, and demonstrate the importance of primary
hematopoietic resources in HIV pathogenesis and the
response to antiretroviral treatments, but also more
generally in the development of immunosenescence.
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